Qingdao Baheal Medical INC. Capital Reinvestment Ratio
Qingdao Baheal Medical INC. capital reinvestment ratio. Qingdao Baheal Medical INC. (301015) has a Capital Reinvestment Ratio of 0.47x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥230.38 Million) in capital expenditures (CN¥107.50 Million). See 301015 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Qingdao Baheal Medical INC. (2018–2025)
Capital reinvestment ratio of Qingdao Baheal Medical INC. from 2018 to 2025. This chart tracks Qingdao Baheal Medical INC.'s Capital Reinvestment Ratio across 7 annual periods. See 301015 financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Qingdao Baheal Medical INC. Capital Reinvestment Ratio by Year (2018–2025)
Qingdao Baheal Medical INC. capital reinvestment ratio by year from 2018 to 2025. For the full cash flow conversion analysis, see 301015 operating cash flow.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.31x | CN¥934.45 Million | CN¥288.93 Million | ▼ -17.2% |
| 2024 | 0.37x | CN¥813.85 Million | CN¥303.99 Million | ▲ +61.0% |
| 2023 | 0.23x | CN¥799.50 Million | CN¥185.49 Million | ▼ -32.6% |
| 2022 | 0.34x | CN¥305.75 Million | CN¥105.32 Million | ▲ +127.2% |
| 2021 | 0.15x | CN¥181.30 Million | CN¥27.49 Million | ▲ +135.9% |
| 2019 | 0.06x | CN¥45.96 Million | CN¥2.95 Million | ▼ -77.3% |
| 2018 | 0.28x | CN¥55.50 Million | CN¥15.74 Million | — |